Search for: "NOVARTIS AG"
Results 101 - 120
of 440
Sorted by Relevance
|
Sort by Date
2 Aug 2007, 4:45 am
Employment Law360 has the scoop (subscription required) on this recently-certified class action:A federal judge in Manhattan has granted class action status to a $200 million gender discrimination lawsuit brought against a subsidiary of Novartis AG by female sales employees. [read post]
28 Jul 2020, 1:00 pm
“To Novartis’ credit, [it] was empowered to function autonomous to Novartis oversight regardless of those findings,” Hahn said. [read post]
2 Dec 2010, 9:28 am
Momenta partnered with Novartis AG’s Sandoz began selling a generic version of the Sanofi-Aventis SA drug Lovenox in July.But note that Teva and Amphastar filed their ANDA applications with the FDA two years before the Momenta-Sandoz partnership filed. [read post]
15 Jun 2010, 3:00 am
With dementia on the rise and as our society continues to age, many pharmaceutical companies are taking aim at inventing a drug that will reduce if not cure dementia all together. [read post]
7 Jun 2008, 3:34 am
Yesterday, Forbes.com reported that Novartis AG spent almost $1.3 million in the first quarter of 2008 on lobbying. [read post]
29 Jan 2021, 2:00 pm
In turn, during 2020 these Beovu side effects caused some eye doctors to avoid using Beovu injections for treatment of neovascular (wet) age-related macular degeneration (AMD). [read post]
17 Jan 2014, 6:43 pm
A link to the Novartis AG v. [read post]
2 Apr 2013, 7:43 am
In a case closely watched by global drugmakers, Switzerland’s Novartis AG has been fighting since 2006 to patent its leukemia-treating drug Glivec in India on the grounds that it is a newer version. [read post]
2 Mar 2019, 9:48 pm
., and Nicholas Mitrokostas of Goodwin Procter, LLP will help patent owners and their counsel navigate both patent prosecution and litigation issues related to patent term by drawing on insights from three recent Federal Circuit decisions: Novartis AG v. [read post]
7 Nov 2019, 8:10 pm
., 37%; Novo Nordisk AS, 17%; Novartis AG, 14%; and Merck KGa, 13%; Hoffmann-La Roche, 12.7%). [read post]
30 Apr 2007, 12:28 pm
In August, 2004, it was able to expand its market share when Zelnorn was given the additional indication for short term treatment of chronic constipation in men and women under the age of 65. [read post]
30 Apr 2007, 12:28 pm
In August, 2004, it was able to expand its market share when Zelnorn was given the additional indication for short term treatment of chronic constipation in men and women under the age of 65. [read post]
19 Mar 2010, 4:13 am
The FDA is considering expanding the warning labels of the Novartis AG cream Elidel (pimecrolimus) and AStellas Pharma’s Protopic (tacrolimus) used to treat eczema. [read post]
1 Sep 2009, 3:03 am
Court of Appeal (Criminal Division) Bastow, R. v [2009] EWCA Crim 1834 (23 July 2009) High Court (Administrative Court) Carter v Crown Prosecution Service [2009] EWHC 2197 (Admin) (27 July 2009) High Court (Patents Court) Novartis AG & Anor v Johnson & Johnson Medical Ltd & Ors [2009] EWHC 2029 (Pat) (29 July 2009) Source: www.bailii.org [...] [read post]
22 Jun 2019, 9:15 am
The landmark judgment of the Supreme Court of India in Novartis AG & Ors. .v. [read post]
1 Oct 2018, 4:30 pm
Back of an eye showing age-related macular degeneration Author US National Eye InstituteSource Wikipedia Jane Lambert Administrative Court (Mrs Justice Whipple) Bayer Plc v NHS Darlington CCG and others [2018] EWHC 2465 (Admin) 21 Sept 2018 These case were applications by Bayer Plc and Novartis Pharmaceuticals UK Ltd. for judicial review of a decision by 12 clinical [read post]
15 Jan 2014, 1:45 pm
The Federal Circuit issued its decision in the pending Patent Term Adjustment (PTA) appeals, resolving the issues raised in Exelixis I, Exelixis II and Novartis, in a precedential decision issued in Novatris AG v. [read post]
23 Jul 2009, 2:30 am
It was decided rather earlier this month, but the ruling of Mr Justice Kitchin in Novartis AG and Cibavision AG v Johnson & Johnson Ltd and another [2009] EWHC 1671 (Pat) has taken a while to reach the top of the IPKat's must-blog pile. 356 paragraphs can take a long time for a Kat to read and, though he hates to admit it, even longer to get the hang of what it's all about.In brief, Novartis claimed that J&J's Acuvue Oasys products… [read post]
17 Jun 2020, 1:15 pm
This FDA regulatory action comes after postmarketing reports of these Beovu vision-loss side effects in 14 patients who received the wet age-related macular degeneration (wet AMD) drug. [read post]
22 May 2017, 9:22 am
The United States Court of Appeals for the Federal Circuit recently issued an opinion in Novartis AG v. [read post]
